Overview:

Summary

Medical device report offering, “Australia Cardiovascular Devices Market Outlook to 2016” provides key market data on the Australia cardiovascular devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices. This medical equipment report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for seven cardiovascular devices market categories – Interventional Cardiology, Peripheral Vascular Devices, Cardiac Rhythm Management, Electrophysiology, Cardiovascular Surgery, Cardiovascular Prosthetic Devices and Cardiovascular Monitoring and Diagnostic Devices.
- Annualized market revenues (USD million), volume (units) and average price ($) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the seven market categories.
- Global corporate-level profiles of key companies operating within the Australia cardiovascular devices market.
- Key players covered include Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical Inc., Cordis Corporation., Abbott Laboratories, Terumo Corporation and C.R. Bard, Inc.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Australia cardiovascular devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

Boston Scientific Corporation
Medtronic, Inc.
St. Jude Medical, Inc.
Cordis Corporation
Abbott Laboratories
Terumo Corporation
BIOTRONIK SE & Co. KG
Biosense Webster, Inc.
C. R. Bard, Inc.
Thoratec Corporation
GE Healthcare
Philips Healthcare
Datascope Corporation
Edwards Lifesciences Corporation
Welch Allyn Inc.
Nihon Kohden Corporation
OSI Systems, Inc.
Sorin S.p.A.
Schiller AG
ABIOMED, Inc.
Cardiac Science Corporation
MAQUET GmbH & Co. KG
ev3 Inc.
Compumedics Limited
AtCor Medical Holdings Limited
Uscom Ltd.
HD Medical Group Limited
Sunshine Heart Company, Pty. Ltd.
Ventracor Limited
CathRx Ltd
BioQ Devices Pty Ltd

1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 What Is This Report About? 17
3 Cardiovascular Devices In Australia 18
3.1 Cardiovascular Devices, Market Segmentation 18
3.2 Cardiovascular Devices, Australia, Overall Revenue ($m), 2002-2016 19
3.3 Cardiovascular Devices Market, Australia, Revenue Mix ($m), 2009 21
3.4 Cardiovascular Devices Market, Australia, Category Contribution (%), 2009 22
3.5 Cardiovascular Devices, Australia, Category Volume (Units), 2002-2016 28
3.6 Cardiovascular Devices, Australia, Company Share (2008-2009) 33
4 Cardiac Rhythm Management In Australia 35
4.1 Cardiac Rhythm Management, Market Segmentation 35
4.2 Cardiac Rhythm Management Market, Australia, Revenue Mix ($m), 2009 36
4.3 Cardiac Rhythm Management Market, Australia, Category Contribution (%), 2009 37
4.4 Cardiac Rhythm Management Overall Revenue (2002-2016) 38
4.4.1 Cardiac Resynchronisation Therapy Revenue (2002-2016) 40
4.4.2 Implantable Cardioverter Defibrillator Revenue (2002-2016) 42
4.4.3 Pacemaker Revenue (2002-2016) 44
4.4.4 External Defibrillator Revenue (2002-2016) 46
4.5 Cardiac Rhythm Management Overall Volume (2002-2016) 48
4.5.1 Cardiac Resynchronisation Therapy Volume (2002-2016) 50
4.5.2 Implantable Cardioverter Defibrillator Volume (2002-2016) 52
4.5.3 Pacemaker Volume (2002-2016) 54
4.5.4 External Defibrillator Volume (2002-2016) 56
4.6 Cardiac Rhythm Management Average Price (2002-2016) 58
4.7 Cardiac Rhythm Management Distribution Share (2008-2009) 60
4.8 Cardiac Rhythm Management, Australia, Company Share (2008-2009) 61
5 Cardiovascular Monitoring and Diagnostic Devices In Australia 63
5.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 63
5.2 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue Mix ($m), 2009 64
5.3 Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Category Contribution (%), 2009 65
5.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2002-2016) 66
5.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2002-2016) 69
5.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2002-2016) 71
5.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2008-2009) 72
5.8 Cardiovascular Monitoring and Diagnostic Devices, Australia, Company Share (2008-2009) 73
6 Cardiovascular Prosthetic Devices In Australia 75
6.1 Cardiovascular Prosthetic Devices, Market Segmentation 75
6.2 Cardiovascular Prosthetic Devices Market, Australia, Revenue Mix ($m), 2009 76
6.3 Cardiovascular Prosthetic Devices Market, Australia, Category Contribution (%), 2009 77
6.4 Cardiovascular Prosthetic Devices Overall Revenue (2002-2016) 78
6.4.1 Cardiac Assist Devices Revenue (2002-2016) 80
6.4.2 Prosthetic Heart Valve Revenue (2002-2016) 82
6.5 Cardiovascular Prosthetic Devices Overall Volume (2002-2016) 84
6.5.1 Cardiac Assist Devices Volume (2002-2016) 86
6.5.2 Prosthetic Heart Valve Volume (2002-2016) 88
6.6 Cardiovascular Prosthetic Devices Average Price (2002-2016) 90
6.7 Cardiovascular Prosthetic Devices Distribution Share (2008-2009) 91
6.8 Cardiovascular Prosthetic Devices, Australia, Company Share (2008-2009) 92
7 Cardiovascular Surgery In Australia 94
7.1 Cardiovascular Surgery, Market Segmentation 94
7.2 Cardiovascular Surgery Market, Australia, Revenue Mix ($m), 2009 95
7.3 Cardiovascular Surgery Market, Australia, Category Contribution (%), 2009 96
7.4 Cardiovascular Surgery Overall Revenue (2002-2016) 97
7.4.1 Perfusion Disposables Revenue (2002-2016) 99
7.5 Cardiovascular Surgery Overall Volume (2002-2016) 101
7.5.1 Perfusion Disposables Volume (2002-2016) 103
7.6 Cardiovascular Surgery Average Price (2002-2016) 105
7.7 Cardiovascular Surgery Distribution Share (2008-2009) 106
7.8 Cardiovascular Surgery, Australia, Company Share (2008-2009) 107
8 Electrophysiology In Australia 108
8.1 Electrophysiology, Market Segmentation 108
8.2 Electrophysiology Market, Australia, Revenue Mix ($m), 2009 109
8.3 Electrophysiology Market, Australia, Category Contribution (%), 2009 110
8.4 Electrophysiology Overall Revenue (2002-2016) 111
8.5 Electrophysiology Overall Volume (2002-2016) 113
8.6 Electrophysiology Average Price (2002-2016) 115
8.7 Electrophysiology Distribution Share (2008-2009) 116
8.8 Electrophysiology, Australia, Company Share (2008-2009) 117
9 Interventional Cardiology In Australia 119
9.1 Interventional Cardiology, Market Segmentation 119
9.2 Interventional Cardiology Market, Australia, Revenue Mix ($m), 2009 120
9.3 Interventional Cardiology Market, Australia, Category Contribution (%), 2009 121
9.4 Interventional Cardiology Overall Revenue (2002-2016) 122
9.4.1 Cardiac Catheter Revenue (2002-2016) 125
9.4.2 Coronary Stent Revenue (2002-2016) 127
9.4.3 PTCA Balloon Revenue (2002-2016) 129
9.5 Interventional Cardiology Overall Volume (2002-2016) 131
9.5.1 Cardiac Catheter Volume (2002-2016) 133
9.5.2 Coronary Stent Volume (2002-2016) 135
9.5.3 PTCA Balloon Volume (2002-2016) 137
9.6 Interventional Cardiology Average Price (2002-2016) 139
9.7 Interventional Cardiology Distribution Share (2008-2009) 141
9.8 Interventional Cardiology, Australia, Company Share (2008-2009) 142
10 Peripheral Vascular Devices In Australia 144
10.1 Peripheral Vascular Devices, Market Segmentation 144
10.2 Peripheral Vascular Devices Market, Australia, Revenue Mix ($m), 2009 145
10.3 Peripheral Vascular Devices Market, Australia, Category Contribution (%), 2009 146
10.4 Peripheral Vascular Devices Overall Revenue (2002-2016) 147
10.5 Peripheral Vascular Devices Overall Volume (2002-2016) 151
10.6 Peripheral Vascular Devices Average Price (2002-2016) 155
10.7 Peripheral Vascular Devices Distribution Share (2008-2009) 157
10.8 Peripheral Vascular Devices, Australia, Company Share (2008-2009) 158
11 Overview of Key Companies in Australia Cardiovascular Devices Market 160
11.1 Boston Scientific Corporation 160
11.1.1 Company Overview 160
11.1.2 Share in the Australia Cardiovascular Devices Market 160
11.2 Medtronic, Inc. 161
11.2.1 Company Overview 161
11.2.2 Share in the Australia Cardiovascular Devices Market 161
11.3 St. Jude Medical, Inc. 162
11.3.1 Company Overview 162
11.3.2 Share in the Australia Cardiovascular Devices Market 162
11.4 Cordis Corporation 163
11.4.1 Company Overview 163
11.4.2 Share in the Australia Cardiovascular Devices Market 163
11.5 Abbott Laboratories 164
11.5.1 Company Overview 164
11.5.2 Share in the Australia Cardiovascular Devices Market 164
11.6 Terumo Corporation 165
11.6.1 Company Overview 165
11.6.2 Share in the Australia Cardiovascular Devices Market 165
11.7 BIOTRONIK SE & Co. KG 166
11.7.1 Company Overview 166
11.8 Biosense Webster, Inc. 166
11.8.1 Company Overview 166
11.9 C. R. Bard, Inc. 166
11.9.1 Company Overview 166
11.10 Thoratec Corporation 167
11.10.1 Company Overview 167
11.11 GE Healthcare 167
11.11.1 Company Overview 167
11.12 Philips Healthcare 168
11.12.1 Company Overview 168
11.13 Datascope Corporation 168
11.13.1 Company Overview 168
11.14 Edwards Lifesciences Corporation 168
11.14.1 Company Overview 168
11.15 Welch Allyn Inc. 169
11.15.1 Company Overview 169
11.16 Nihon Kohden Corporation 169
11.16.1 Company Overview 169
11.17 OSI Systems, Inc. 170
11.17.1 Company Overview 170
11.18 Sorin S.p.A. 170
11.18.1 Company Overview 170
11.19 Schiller AG 171
11.19.1 Company Overview 171
11.20 ABIOMED, Inc. 171
11.20.1 Company Overview 171
11.21 Cardiac Science Corporation 171
11.21.1 Company Overview 171
11.22 MAQUET GmbH & Co. KG 172
11.22.1 Company Overview 172
11.23 ev3 Inc. 172
11.23.1 Company Overview 172
11.24 Compumedics Limited 173
11.24.1 Company Overview 173
11.25 AtCor Medical Holdings Limited 173
11.25.1 Company Overview 173
11.26 Uscom Ltd. 173
11.26.1 Company Overview 173
11.27 HD Medical Group Limited 174
11.27.1 Company Overview 174
11.28 Sunshine Heart Company, Pty. Ltd. 174
11.28.1 Company Overview 174
11.29 Ventracor Limited 174
11.29.1 Company Overview 174
11.30 CathRx Ltd 175
11.30.1 Company Overview 175
11.31 BioQ Devices Pty Ltd 175
11.31.1 Company Overview 175
12 Cardiovascular Devices Market Pipeline Products 176
13 Financial Deals Landscape 187
13.1 Acquisition 187
13.1.1 Thoratec Terminates Its Acquisition Of HeartWare International 187
13.2 Partnerships 189
13.2.1 Cardiac Network Signs Licensing Agreement with Pacific Innovations 189
13.2.2 Coherex Medical Enters Into Distribution Agreement With Abbott Laboratories 190
13.2.3 Masimo Enters Into Licensing Agreement With GS Electro Medical Equipment 191
14 Recent Developments 192
14.1 Strategy And Business Planning 192
14.1.1 Oct 10, 2009: Ambu Opens New Entity, Ambu Australia 192
14.2 Government and Public Interest 192
14.2.1 Apr 26, 2010: HeartWare Initiates Repairs And Partial Recall Of Controllers 192
14.2.2 Sep 30, 2009: Study Says Novel Catheter-Based Technique Reduces Resistant Hypertension 193
14.3 Product News 194
14.3.1 Oct 08, 2009: Zenith TX2 TAA Endovascular Graft With Pro-Form From Cook Treats First Patients In Australia 194
14.3.2 Sep 29, 2009: St. Jude Medical Launches New Cardiac Rhythm Management Devices In Australia 195
15 Appendix 196
15.1 Definitions of Markets Covered in the Report 197
15.1.1 Cardiovascular Devices 197
15.2 Research Methodology 204
15.3 Secondary Research 205
15.4 Primary Research 205
15.5 Models 206
15.6 Forecasts 206
15.7 Expert Panels 206
15.8 GlobalData Consulting 206
15.9 Currency Conversion 207
15.10 Contact Us 207
15.11 Disclaimer 207

1.1 List of Tables
Table 1: Cardiovascular Devices, Australia, Overall Revenue ($m), 2002-2016 20
Table 2: Cardiovascular Devices Market, Australia, Category Contribution (%), 2009 22
Table 3: Cardiovascular Devices Market, Australia, Cross-Segment Analysis,2002-2016 23
Table 4: Cardiovascular Devices, Australia, Overall Revenue ($m), Historic, 2002-2009 25
Table 5: Cardiovascular Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016 27
Table 6: Cardiovascular Devices, Australia, Category Volume (Units), 2002-2016 28
Table 7: Cardiovascular Devices, Australia, Category Volume (Units), Historic, 2002-2009 30
Table 8: Cardiovascular Devices, Australia, Category Volume (Units), Forecast, 2009-2016 32
Table 9: Cardiovascular Devices, Australia, Company Share by Revenue ($m), 2008-2009 34
Table 10: Cardiac Rhythm Management Market, Australia, Category Contribution (%), 2009 37
Table 11: Cardiac Rhythm Management, Australia, Revenue ($m) by Segment, Historic, 2002-2009 38
Table 12: Cardiac Rhythm Management, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 39
Table 13: Cardiac Resynchronisation Therapy, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 14: Cardiac Resynchronisation Therapy, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Table 15: Implantable Cardioverter Defibrillator, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 42
Table 16: Implantable Cardioverter Defibrillator, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 43
Table 17: Pacemaker, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 44
Table 18: Pacemaker, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 45
Table 19: External Defibrillator, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 46
Table 20: External Defibrillator, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 47
Table 21: Cardiac Rhythm Management, Australia, Volume (Units) by Segment, Historic, 2002-2009 48
Table 22: Cardiac Rhythm Management, Australia, Volume (Units) by Segment, Forecast, 2009-2016 49
Table 23: Cardiac Resynchronisation Therapy, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 50
Table 24: Cardiac Resynchronisation Therapy, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 51
Table 25: Implantable Cardioverter Defibrillator, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 52
Table 26: Implantable Cardioverter Defibrillator, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 53
Table 27: Pacemaker, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 54
Table 28: Pacemaker, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 55
Table 29: External Defibrillator, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 56
Table 30: External Defibrillator, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 57
Table 31: Cardiac Rhythm Management, Australia, Average Price ($), Historic, 2002-2009 58
Table 32: Cardiac Rhythm Management, Australia, Average Price ($), Forecast,, 2009-2016 59
Table 33: Cardiac Rhythm Management, Australia, Distribution Share by Revenue ($m), 2008-2009 60
Table 34: Cardiac Rhythm Management, Australia, Company Share by Revenue ($m), 2008-2009 62
Table 35: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Category Contribution (%), 2009 65
Table 36: Cardiovascular Monitoring and Diagnostic Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 67
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 68
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 69
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 70
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Australia, Average Price ($), Historic, 2002-2009 71
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Australia, Average Price ($), Forecast,, 2009-2016 71
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Australia, Distribution Share by Revenue ($m), 2008-2009 72
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Australia, Company Share by Revenue ($m), 2008-2009 74
Table 44: Cardiovascular Prosthetic Devices Market, Australia, Category Contribution (%), 2009 77
Table 45: Cardiovascular Prosthetic Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 78
Table 46: Cardiovascular Prosthetic Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 79
Table 47: Cardiac Assist Devices, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 80
Table 48: Cardiac Assist Devices, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
Table 49: Prosthetic Heart Valve, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 82
Table 50: Prosthetic Heart Valve, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 83
Table 51: Cardiovascular Prosthetic Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 84
Table 52: Cardiovascular Prosthetic Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 85
Table 53: Cardiac Assist Devices, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 86
Table 54: Cardiac Assist Devices, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 87
Table 55: Prosthetic Heart Valve, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 88
Table 56: Prosthetic Heart Valve, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 89
Table 57: Cardiovascular Prosthetic Devices, Australia, Average Price ($), Historic, 2002-2009 90
Table 58: Cardiovascular Prosthetic Devices, Australia, Average Price ($), Forecast,, 2009-2016 90
Table 59: Cardiovascular Prosthetic Devices, Australia, Distribution Share by Revenue ($m), 2008-2009 91
Table 60: Cardiovascular Prosthetic Devices, Australia, Company Share by Revenue ($m), 2008-2009 93
Table 61: Cardiovascular Surgery Market, Australia, Category Contribution (%), 2009 96
Table 62: Cardiovascular Surgery, Australia, Revenue ($m) by Segment, Historic, 2002-2009 97
Table 63: Cardiovascular Surgery, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 98
Table 64: Perfusion Disposables, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 99
Table 65: Perfusion Disposables, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 100
Table 66: Cardiovascular Surgery, Australia, Volume (Units) by Segment, Historic, 2002-2009 101
Table 67: Cardiovascular Surgery, Australia, Volume (Units) by Segment, Forecast, 2009-2016 102
Table 68: Perfusion Disposables, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 103
Table 69: Perfusion Disposables, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 104
Table 70: Cardiovascular Surgery, Australia, Average Price ($), Historic, 2002-2009 105
Table 71: Cardiovascular Surgery, Australia, Average Price ($), Forecast,, 2009-2016 105
Table 72: Cardiovascular Surgery, Australia, Distribution Share by Revenue ($m), 2008-2009 106
Table 73: Cardiovascular Surgery, Australia, Company Share by Revenue ($m), 2008-2009 107
Table 74: Electrophysiology Market, Australia, Category Contribution (%), 2009 110
Table 75: Electrophysiology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 111
Table 76: Electrophysiology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 112
Table 77: Electrophysiology, Australia, Volume (Units) by Segment, Historic, 2002-2009 113
Table 78: Electrophysiology, Australia, Volume (Units) by Segment, Forecast, 2009-2016 114
Table 79: Electrophysiology, Australia, Average Price ($), Historic, 2002-2009 115
Table 80: Electrophysiology, Australia, Average Price ($), Forecast,, 2009-2016 115
Table 81: Electrophysiology, Australia, Distribution Share by Revenue ($m), 2008-2009 116
Table 82: Electrophysiology, Australia, Company Share by Revenue ($m), 2008-2009 118
Table 83: Interventional Cardiology Market, Australia, Category Contribution (%), 2009 121
Table 84: Interventional Cardiology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 123
Table 85: Interventional Cardiology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 124
Table 86: Cardiac Catheter, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 125
Table 87: Cardiac Catheter, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 126
Table 88: Coronary Stent, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 127
Table 89: Coronary Stent, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 128
Table 90: PTCA Balloon, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 129
Table 91: PTCA Balloon, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 130
Table 92: Interventional Cardiology, Australia, Volume (Units) by Segment, Historic, 2002-2009 131
Table 93: Interventional Cardiology, Australia, Volume (Units) by Segment, Forecast, 2009-2016 132
Table 94: Cardiac Catheter, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 133
Table 95: Cardiac Catheter, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 134
Table 96: Coronary Stent, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 135
Table 97: Coronary Stent, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 136
Table 98: PTCA Balloon, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 137
Table 99: PTCA Balloon, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 138
Table 100: Interventional Cardiology, Australia, Average Price ($), Historic, 2002-2009 139
Table 101: Interventional Cardiology, Australia, Average Price ($), Forecast,, 2009-2016 140
Table 102: Interventional Cardiology, Australia, Distribution Share by Revenue ($m), 2008-2009 141
Table 103: Interventional Cardiology, Australia, Company Share by Revenue ($m), 2008-2009 143
Table 104: Peripheral Vascular Devices Market, Australia, Category Contribution (%), 2009 146
Table 105: Peripheral Vascular Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 148
Table 106: Peripheral Vascular Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 150
Table 107: Peripheral Vascular Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 152
Table 108: Peripheral Vascular Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 154
Table 109: Peripheral Vascular Devices, Australia, Average Price ($), Historic, 2002-2009 155
Table 110: Peripheral Vascular Devices, Australia, Average Price ($), Forecast,, 2009-2016 156
Table 111: Peripheral Vascular Devices, Australia, Distribution Share by Revenue ($m), 2008-2009 157
Table 112: Peripheral Vascular Devices, Australia, Company Share by Revenue ($m), 2008-2009 159
Table 113: Cardiovascular Devices Market Pipeline Products 176
Table 114: Thoratec Terminates Its Acquisition Of HeartWare International 187
Table 115: Cardiac Network Signs Licensing Agreement With Pacific Innovations 189
Table 116: Coherex Medical Enters Into Distribution Agreement With Abbott Laboratories 190
Table 117: Masimo Enters Into Licensing Agreement With GS Electro Medical Equipment 191
Table 118: USD to Local Currency, Australia, Average Actual Rate 2002-2009 207

1.2 List of Figures
Figure 1: Cardiovascular Devices, Market Segmentation 18
Figure 2: Cardiovascular Devices, Australia, Overall Revenue ($m), 2002-2016 19
Figure 3: Cardiovascular Devices Market, Australia, Revenue Mix ($m), 2009 21
Figure 4: Cardiovascular Devices Market, Australia, Category Contribution (%), 2009 22
Figure 5: Cardiovascular Devices Market, Australia, Cross-Segment Analysis,2002-2016 23
Figure 6: Cardiovascular Devices, Australia, Overall Revenue ($m), Historic, 2002-2009 24
Figure 7: Cardiovascular Devices, Australia, Overall Revenue ($m), Forecast, 2009-2016 26
Figure 8: Cardiovascular Devices, Australia, Category Volume (Units), 2002-2016 28
Figure 9: Cardiovascular Devices, Australia, Category Volume (Units), Historic, 2002-2009 29
Figure 10: Cardiovascular Devices, Australia, Category Volume (Units), Forecast, 2009-2016 31
Figure 11: Cardiovascular Devices, Australia, Company Share (%), 2009 33
Figure 12: Cardiac Rhythm Management, Market Segmentation 35
Figure 13: Cardiac Rhythm Management Market, Australia, Revenue Mix ($m), 2009 36
Figure 14: Cardiac Rhythm Management Market, Australia, Category Contribution (%), 2009 37
Figure 15: Cardiac Rhythm Management, Australia, Revenue ($m) by Segment, Historic, 2002-2009 38
Figure 16: Cardiac Rhythm Management, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 39
Figure 17: Cardiac Resynchronisation Therapy, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Figure 18: Cardiac Resynchronisation Therapy, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 19: Implantable Cardioverter Defibrillator, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 42
Figure 20: Implantable Cardioverter Defibrillator, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 43
Figure 21: Pacemaker, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 44
Figure 22: Pacemaker, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 45
Figure 23: External Defibrillator, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 46
Figure 24: External Defibrillator, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 47
Figure 25: Cardiac Rhythm Management, Australia, Volume (Units) by Segment, Historic, 2002-2009 48
Figure 26: Cardiac Rhythm Management, Australia, Volume (Units) by Segment, Forecast, 2009-2016 49
Figure 27: Cardiac Resynchronisation Therapy, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 50
Figure 28: Cardiac Resynchronisation Therapy, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 51
Figure 29: Implantable Cardioverter Defibrillator, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 52
Figure 30: Implantable Cardioverter Defibrillator, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 53
Figure 31: Pacemaker, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 54
Figure 32: Pacemaker, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 55
Figure 33: External Defibrillator, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 56
Figure 34: External Defibrillator, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 57
Figure 35: Cardiac Rhythm Management, Australia, Company Share (%), 2009 61
Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 63
Figure 37: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Revenue Mix ($m), 2009 64
Figure 38: Cardiovascular Monitoring and Diagnostic Devices Market, Australia, Category Contribution (%), 2009 65
Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 66
Figure 40: Cardiovascular Monitoring and Diagnostic Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 68
Figure 41: Cardiovascular Monitoring and Diagnostic Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 69
Figure 42: Cardiovascular Monitoring and Diagnostic Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 70
Figure 43: Cardiovascular Monitoring and Diagnostic Devices, Australia, Company Share (%), 2009 73
Figure 44: Cardiovascular Prosthetic Devices, Market Segmentation 75
Figure 45: Cardiovascular Prosthetic Devices Market, Australia, Revenue Mix ($m), 2009 76
Figure 46: Cardiovascular Prosthetic Devices Market, Australia, Category Contribution (%), 2009 77
Figure 47: Cardiovascular Prosthetic Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 78
Figure 48: Cardiovascular Prosthetic Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 79
Figure 49: Cardiac Assist Devices, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 80
Figure 50: Cardiac Assist Devices, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
Figure 51: Prosthetic Heart Valve, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 82
Figure 52: Prosthetic Heart Valve, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 83
Figure 53: Cardiovascular Prosthetic Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 84
Figure 54: Cardiovascular Prosthetic Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 85
Figure 55: Cardiac Assist Devices, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 86
Figure 56: Cardiac Assist Devices, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 87
Figure 57: Prosthetic Heart Valve, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 88
Figure 58: Prosthetic Heart Valve, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 89
Figure 59: Cardiovascular Prosthetic Devices, Australia, Company Share (%), 2009 92
Figure 60: Cardiovascular Surgery, Market Segmentation 94
Figure 61: Cardiovascular Surgery Market, Australia, Revenue Mix ($m), 2009 95
Figure 62: Cardiovascular Surgery Market, Australia, Category Contribution (%), 2009 96
Figure 63: Cardiovascular Surgery, Australia, Revenue ($m) by Segment, Historic, 2002-2009 97
Figure 64: Cardiovascular Surgery, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 98
Figure 65: Perfusion Disposables, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 99
Figure 66: Perfusion Disposables, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 100
Figure 67: Cardiovascular Surgery, Australia, Volume (Units) by Segment, Historic, 2002-2009 101
Figure 68: Cardiovascular Surgery, Australia, Volume (Units) by Segment, Forecast, 2009-2016 102
Figure 69: Perfusion Disposables, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 103
Figure 70: Perfusion Disposables, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 104
Figure 71: Cardiovascular Surgery, Australia, Company Share (%), 2009 107
Figure 72: Electrophysiology, Market Segmentation 108
Figure 73: Electrophysiology Market, Australia, Revenue Mix ($m), 2009 109
Figure 74: Electrophysiology Market, Australia, Category Contribution (%), 2009 110
Figure 75: Electrophysiology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 111
Figure 76: Electrophysiology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 112
Figure 77: Electrophysiology, Australia, Volume (Units) by Segment, Historic, 2002-2009 113
Figure 78: Electrophysiology, Australia, Volume (Units) by Segment, Forecast, 2009-2016 114
Figure 79: Electrophysiology, Australia, Company Share (%), 2009 117
Figure 80: Interventional Cardiology, Market Segmentation 119
Figure 81: Interventional Cardiology Market, Australia, Revenue Mix ($m), 2009 120
Figure 82: Interventional Cardiology Market, Australia, Category Contribution (%), 2009 121
Figure 83: Interventional Cardiology, Australia, Revenue ($m) by Segment, Historic, 2002-2009 122
Figure 84: Interventional Cardiology, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 124
Figure 85: Cardiac Catheter, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 125
Figure 86: Cardiac Catheter, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 126
Figure 87: Coronary Stent, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 127
Figure 88: Coronary Stent, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 128
Figure 89: PTCA Balloon, Australia, Revenue ($m) by Sub-Segment, Historic, 2002-2009 129
Figure 90: PTCA Balloon, Australia, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 130
Figure 91: Interventional Cardiology, Australia, Volume (Units) by Segment, Historic, 2002-2009 131
Figure 92: Interventional Cardiology, Australia, Volume (Units) by Segment, Forecast, 2009-2016 132
Figure 93: Cardiac Catheter, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 133
Figure 94: Cardiac Catheter, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 134
Figure 95: Coronary Stent, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 135
Figure 96: Coronary Stent, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 136
Figure 97: PTCA Balloon, Australia, Volume (Units) by Sub-Segment, Historic, 2002-2009 137
Figure 98: PTCA Balloon, Australia, Volume (Units) by Sub-Segment, Forecast, 2009-2016 138
Figure 99: Interventional Cardiology, Australia, Company Share (%), 2009 142
Figure 100: Peripheral Vascular Devices, Market Segmentation 144
Figure 101: Peripheral Vascular Devices Market, Australia, Revenue Mix ($m), 2009 145
Figure 102: Peripheral Vascular Devices Market, Australia, Category Contribution (%), 2009 146
Figure 103: Peripheral Vascular Devices, Australia, Revenue ($m) by Segment, Historic, 2002-2009 147
Figure 104: Peripheral Vascular Devices, Australia, Revenue ($m) by Segment, Forecast, 2009-2016 149
Figure 105: Peripheral Vascular Devices, Australia, Volume (Units) by Segment, Historic, 2002-2009 151
Figure 106: Peripheral Vascular Devices, Australia, Volume (Units) by Segment, Forecast, 2009-2016 153
Figure 107: Peripheral Vascular Devices, Australia, Company Share (%), 2009 158
Figure 108: Boston Scientific Corporation, Company Share (%), Australia Cardiovascular Devices Market, 2009 160
Figure 109: Medtronic, Inc., Company Share (%), Australia Cardiovascular Devices Market, 2009 161
Figure 110: St. Jude Medical, Inc., Company Share (%), Australia Cardiovascular Devices Market, 2009 162
Figure 111: Cordis Corporation, Company Share (%), Australia Cardiovascular Devices Market, 2009 163
Figure 112: Abbott Laboratories, Company Share (%), Australia Cardiovascular Devices Market, 2009 164
Figure 113: Terumo Corporation, Company Share (%), Australia Cardiovascular Devices Market, 2009 165
Figure 114: GlobalData Methodology 204